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Summary The association between epilepsy and erectile dysfunction (ED) has often
been described but not clearly deﬁned. This is a review of the literature regarding
the current theories on the causes of ED in epilepsy, as well as the evaluation and
treatment options available.
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The association between epilepsy and erectile
dysfunction (ED) has often been described but not
clearly deﬁned. Sexual dysfunction as a disorder
is complex and often multifactorial, with medical,
psychological, and life circumstances all playing im-
portant roles. Epileptic men have been found to
have an increased risk of ED of up to 57%1 compared
to 3–9% in the general population.2,3 There has not
been a consensus regarding the prevalence of ED in
patients with epilepsy. Studies have indicated that
the prevalence of ED varies within particular epilep-
tic patient populations, with the frequency being
as low as 3% in outpatient populations4 to as high
as 58% in patients evaluated for epilepsy surgery.5
There are many sexual disorders that have been
described as having a connection with epilepsy,
such as self-mutilation and sadomasochism,6
exhibitionism,6,7 and fetishism.8 The dysfunction
most often mentioned by patients includes de-
creased desire, reduced potency, and impaired
sexual performance. However, recent studies have
suggested that epilepsy interferes speciﬁcally with
physiological dysfunction while sexual desire re-
mains unaffected.9,10 The most common form of
sexual dysfunction that has been described has been
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that of hyposexuality, deﬁned as a global reduction
in sexual interest, awareness, and activity.11
Certain sexual disorders have been associated
with speciﬁc periods of seizure activity, and fall
into two discrete categories: those directly related
to the epileptic discharge period (ictal), and those
unrelated in time to seizure occurrence (interic-
tal). Hypersexuality has been connected to ictal
seizure activity12,13 while hyposexuality has been
linked to interictal seizure activity.13,14
The speciﬁc locus of epileptiform discharge
leading to erectile dysfunction has also been the
subject of scrutiny and debate. It has been pos-
tulated that patients with temporal lobe epilepsy
(TLE) appear more prone to hypogonadism and
sexual abnormality.14–18 It has also been estab-
lished that TLE is more common in men.19 There
have been several studies linking hyposexuality to
focal seizures,14,20–23 particularly those with TLE
compared to patients with primary generalized
epilepsy. Shukla et al.14 studied 44 adults with TLE,
and 47 adults with primary generalized epilepsy.
They found that 63% of men and 64% of women
with TLE were hyposexual while 12% of men and 8%
of women with generalized epilepsy.
Gastaut and Collomb20 postulated that onset
of seizures prior to or during puberty may have a
marked effect on the hypothalamic-pituitary axis
affecting normal sexual development, attitudes,
and behavior. Research supporting this theory found
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that there were higher levels of gonadotropins in
patients with onset of epilepsy prior to the age of
14,1 and that men whose epilepsy had undergone
remission by the age of 12 years were more likely
to have normal sexual performance and be more
likely to marry.24 These ﬁndings have been disputed
in numerous recent studies,3,10,18,21 all of which
found that there was no correlation between the
age of onset of epilepsy and sexual dysfunction.
A correlation between hyposexuality and the
severity or frequency of seizure episodes has been
described. Studies have found increased incidence
of erectile dysfunction in times of stress or in-
creased seizure frequency5,25,26 as well as patients
being assessed for epilepsy surgery.6,8 Addition-
ally, studies found lower rates of hyposexuality
in patients with increased duration of seizure
freedom,5,18 indicating that adequate treatment
of epilepsy may lead to an improvement in sex-
ual function. Taylor6 evaluated 100 patients who
had surgical intervention for TLE, pre- and post-
operatively. Prior to surgery, 86 had pre-operative
evidence of sexual dysfunction. Postoperatively,
14 patients were free of sexual dysfunction, 22
patients showed improved sexual dysfunction, 36
showed no change in sexual function, and 14 pa-
tients showed decreased sexual function from their
baseline, which at the time was attributed to the
advanced age of this patient group. It was ob-
served that patients showing the greatest improve-
ment in sexual function had also demonstrated
marked or complete seizure relief. In comparison,
other researchers have found no correlation be-
tween sexual dysfunction and seizure frequency
or severity.1,3,10,20,22,27 Christianson et al.27 ob-
served no difference in post-operative sexual
function even though 59% of patients experienced
post-operative control of epileptic activity.
Epileptic discharge as a causative
factor
Epileptic seizures have been linked to changes
in autonomic nervous system function. During
generalized tonic–clonic seizures, these changes
are thought to be non-speciﬁc, while in par-
tial seizures these discharges are thought to be
discrete and speciﬁc.28 Epileptiform discharges
from the temporal lobe region may be transmit-
ted through amygdala-hypothalamic pathways,
disrupting the normal pulsatile secretion of go-
nadotropic hormones and the basal levels of
dopamine secretion, resulting in hypogonadism
and hyperprolactinemia.29 Conﬁrming this obser-
vation, Feeney et al.30 reported acute cessation
(between 1 and 16 weeks) of sexual behavior in
four male cats after the induction of focal amyg-
dala epileptiform activity by unilateral injec-
tion of aluminum hydroxide. Other investigators
have supported the concept that temporal lobe
epileptiform discharge has a modulating effect on
neuroendocrine function, indicating that epilep-
tiform discharges from the amygdala results in
pulses of transient hyperprolactinemia31 and se-
lective lesions of the temporal lobe limbic com-
plex cause hypogonadotropic hypogonadism and
hyperprolactinemia.29
Hormonal issues and erectile dysfunction
in epileptics
The center of control of the reproductive sys-
tem resides in the nuclei of the medial basal
hypothalamus.32 Hypothalamic function is affected
by several interrelated regulatory mechanisms,
including hormonal feedback from gonadotropins
and steroid hormones, as well as direct input from
higher neurologic structures. In males, low levels
of serum free testosterone results in the increased
production of gonadotropin releasing hormone by
the hypothalamic nuclei, resulting in the increased
release of luteinizing hormone from the pituitary.
Luteinizing hormone acts on the Leydig cells of the
testes to both increase production of and release
testosterone and dihydrotestosterone.33
Testosterone exists in three distinct forms in the
bloodstream: free (2–3%), albumin bound (53–55%),
and sex hormone binding globulin bound (43–45%).34
Free testosterone and the large constituent of al-
bumin bound testosterone are available to tissues,
constituting active testosterone, while the sex
hormone binding globulin bound portion is unavail-
able to tissues and is not considered biologically
active.35
Hormonal changes resulting in the alteration of
normal levels of biologically active testosterone
may contribute to the sexual dysfunction observed
in epileptic patients.15,29,36,37 Herzog et al.15 as-
sessed 20 men with TLE and found that of 11 (55%)
of these patients had hyposexuality. Reproductive
disorders were found in 9 of these 11 patients; 5
cases of hypogonadotropic hypogonadism, 2 cases
of hyperprolactinemia, and 2 cases of hyperg-
onadotropic hypogonadism. From a different per-
spective, Spark et al.29 examined 16 men referred
for hyposexuality. Eleven of these patients were
diagnosed with TLE, while six were diagnosed with
neuroendocrine abnormalities; four patients with
low free testosterone and two patients with hyper-
prolactinemia. Their criteria for epilepsy diagnosis
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(sleep-deprived sleep EEG in addition to clinical
symptoms sudden syncope, fugue states, vertigo,
auditory hallucinations, recurrent abdominal pain,
major motor seizures), has been questioned by
others.38,39 While these criteria may be unconvinc-
ing for the proper diagnosis of epilepsy, this study
is important because the patients who were na¨ıve
to antiepileptic drugs, illustrating the concept that
epileptiform discharge itself may directly lead to
alterations in neuroendocrine function resulting in
sexual dysfunction.
Several changes in hormonal levels have been
observed in epileptic patients. Serum prolactin
has been reported to rise within 20min in both
generalized seizures or those induced with elec-
troconvulsive therapy.40 Increased prolactin lev-
els have also been observed in two thirds of pa-
tients having seizures of frontal or temporal lobe
origin.41 In a recent review article by Lambert,42 it
was reported that most patients with generalized
seizures,41,43–45 and 39–100% of patients with com-
plex partial seizures31,41,45–47 have rises in serum
prolactin, compared to less than 10% of patients
with simple partial seizures.41 Furthermore, it has
been observed that complex partial seizures of
frontal lobe origin were less likely to be associated
with an elevation of serum prolactin than seizures
of temporal lobe origin.48 The existence of per-
sistent reproductive endocrine abnormalities in
men with epilepsy is also suggested by interictal
ﬁndings of abnormal serum testosterone and go-
nadotropin concentrations,15 and altered luteiniz-
ing hormone responses to gonadotropin releasing
hormone stimulation.49 In their sample of 37 epilep-
tic men, Murialdo et al.18 reported lower levels of
free testosterone, DHT, and increased sex hormone
binding globulin. A more recent study37 examined
22 men with medically intractable epilepsy, both
pre- and post-temporal lobe surgery. Fourteen
of these patients became seizure free following
surgery. In half of these seizure-free patients, total
testosterone, free testosterone, and androstene-
dione increased, even though anticonvulsant med-
ications were maintained. Patients who failed to
become seizure-free postoperatively did not show
signiﬁcant alterations in hormonal levels. Patients
with low total and free testosterone tend to have
reduced nocturnal penile tumescence and dimin-
ished sexual activity,50 and levels of DHT have been
positively correlated with frequency of orgasm in
healthy men.51 Increases in serum estradiol have
been described in epileptic patients as well,18,52
but in each of these studies the patients were
currently receiving antiepileptic therapy. Although
studies have documented changes in hormone lev-
els in epileptic patients, it is important to also
consider the role of antiepileptic pharmacotherapy
as a causative factor.
Role of medication induced erectile
dysfunction
There is plentiful evidence to suggest that antiepil-
eptic drugs alter the serum concentrations of sex
hormones and the regulatory feedback loop of the
hypothalamic-pituitary-gonadal axis by a number of
mechanisms. This is thought to contribute to the
sexual dysfunction observed in epileptic patients
who chronically receive antiepileptic medications.
The extent of its role in sexual dysfunction versus
that of psychosocial issues and the effects of epilep-
tiform discharge is much less clear. There have been
a number of studies examining epilepsy and alter-
ations in hormonal levels, but in a vast majority
of these studies the subjects were concurrently re-
ceiving antiepileptic drug therapy making it difﬁ-
cult to discern causality.
Conney53 reported that phenytoin, phenobarbi-
tal, and testosterone are hydroxylated by a com-
mon hepatic microsomal enzyme system, increasing
the metabolism and clearance of free testosterone
and lowering the serum level of free testosterone.
Decreased levels in urine 17-ketosteroid concen-
trations have been reported in patients receiving
antiepileptic medications as well.54,55 It has also
been proposed that the use of antiepileptic med-
ications is associated with increased circulating
levels of sex hormone binding globulin.56 Barragry
et al.57 found that levels of serum testosterone
and sex hormone binding globulin were elevated in
treated epileptic male subjects. Researchers15,57,58
theorized that despite normal pituitary and tes-
ticular regulatory function, increased hepatic syn-
thesis and secretion of sex hormone binding glob-
ulin results in elevated serum total testosterone
concentrations, yet decreases serum free testos-
terone. Toone et al.59 conﬁrmed the ﬁnding of low-
ered serum free testosterone in treated epileptic
men, and found an association between lower free
testosterone and higher serum gonadotropin levels.
In addition, phenytoin has been associated with
an increase in estradiol concentrations,18,52 which
raises the possibility that in addition to induc-
ing the synthesis and secretion of sex hormone
binding globulin, it may also induce aromatase,
converting free testosterone to estradiol.60 Al-
though estradiol makes up approximately 1% of
a male’s total steroid sex hormones, it consti-
tutes almost 50% of the negative feedback on
male luteinizing hormone secretion.61,62 Thus,
an increase in estradiol leading to suppression of
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luteinizing hormone secretion would result in a
hypogonadotropic hypogonadism state.35 Estradiol
has also been associated with premature aging of
the hypothalamic arcuate nucleus,63,64 which could
also potentially lead to the development of hy-
pogonadotropic hypogonadism.65 Finally, estradiol
increases the synthesis and secretion of sex hor-
mone binding globulin66 which would alter levels
of free testosterone as described above. The re-
sulting decreased levels of free testosterone would
produce a critically low ratio of free testosterone
to estradiol, which could clinically manifest itself
as hyposexuality.35
It is not plausible to consider anticonvulsant
medication as the sole cause of sexual dysfunc-
tion in epileptic patients. Researchers studying
patient populations na¨ıve to antiepileptic medica-
tions have documented evidence of hyposexuality,
thus disputing the role of antiepileptic medications
in sexual dysfunction. Gastaut and Collomb20 ob-
served hyposexuality in two third of their patients,
none of whom were receiving antiepileptic ther-
apy. In another study, 15 patients with both TLE
and erectile dysfunction were observed.67 In three
of these patients, the development of sexual dys-
function preceded the development of epilepsy by
at least 6 months. During this time interval, these
patients received no antiepileptic medical treat-
ment. Bauer et al.37 reported that sex hormone
levels normalized in half of the patients who un-
derwent successful epilepsy surgery, despite con-
tinued medical treatment. However, most studies
implicate medical therapy as a contributing fac-
tor to sexual dysfunction in epileptics. Supporting
this theory, Connel et al.68 administered carba-
mazepine to a series of patients who did not have
epilepsy, and found a rise in sex hormone binding
globulin and decreases in total testosterone, free
testosterone, and DHT within 7 days of starting the
medication. However, within 3 weeks of continued
therapy, hormonal levels normalized.
Diagnostic workup
There are several different etiologies in the patho-
genesis of erectile dysfunction in patients with
epilepsy. It is likely that epilepsy itself, antiepilep-
tic drugs, and psychosocial factors all play a role.
The initial evaluation of any patient with erectile
dysfunction should include a full endocrine workup,
psychological screening and evaluation, complete
sexual and relationship history, medication history,
and a nocturnal penile tumescence evaluation.
Serum levels of free testosterone, estradiol, and
prolactin should be obtained. A full screening for
depression and anxiety disorders should be ob-
tained. While this can be done in the ofﬁce or
outpatient setting, consultation with a psychol-
ogist may be warranted. At the same time, it is
important to elicit a full sexual and relationship
history. There are innumerable contributing factors
to erectile dysfunction, and any evaluation would
be incomplete without considering life stressors in
its etiology. Finally, nocturnal penile tumescence
should be evaluated. Diminished rigidity has been
shown to be associated with inability to initiate
and maintain penetration69 and predicts the ab-
sence of spontaneous morning erections.70 This
can assist in the differentiation between organic
and psychogenic erectile dysfunction.71 Physio-
logical erectile dysfunction should impair daytime
and nocturnal erections equally. Finally, impaired
tumescence is associated with vasogenic erectile
dysfunction while impaired rigidity is associated
with neurogenic erectile dysfunction.50 Tumes-
cence and rigidity can be measured by ambulatory
units that are both cost efﬁcient and more accurate
than home devices.72
Treatment options
Once the etiology of sexual dysfunction has been
determined, a proper treatment strategy may be
implemented. For years the approach in treating
patients with neuroendocrine dysfunction and TLE
was to ﬁrst treat the epilepsy with anticonvulsant
medications and then, if hormone abnormalities
and symptoms persisted, add supplemental hor-
monal therapy. In one study, four of ﬁve hyposexual
patients with TLE were treated with anticonvul-
sant therapy alone and while seizure activity was
controlled, hyposexuality persisted, requiring the
use of parenteral testosterone or bromocriptine.29
Daniels et al.73 found that improvement in sexual
functioning accompanied improved seizure control
in a placebo-controlled study of intra-muscular
testosterone. However, Herzog35 reported that
testosterone was only moderately effective in
restoring reproductive and sexual function. He
postulated that this was due to the induction of
aromatase and the subsequent increase in estradiol
levels and its effects on sexual function. Guldner
and Morrell72 reported that if erectile dysfunction
appears to be physiologically mediated, it is im-
portant to examine pharmacologic therapy. Both
improved seizure control and erectile response
may be attained by changing antiepileptic medi-
cations or increasing non-barbituate antiepileptic
medications.67,74 Rattya et al.58 examined the
effects of carbamazepine, oxcarbazepine, and
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valproate in epileptic men and found that car-
bamazepine is associated with a progressive in-
crease in circulating levels of sex hormone binding
globulin. This conﬁrmed the results of prior stud-
ies. However, they found that oxcarbazepine, a
keto-derivative of carbamazepine metabolized in
the liver by reduction instead of oxidation, does
not induce the oxidative p450 enzyme system to
the same extent as carbamazepine, although these
liver enzymes are progressively induced at higher
doses. Thus, oxcarbazepine may be a more ef-
fective form of treatment in epileptic patients
suffering from hyposexuality.
Symptomatic approaches to the treatment of
erectile dysfunction can be implemented either
in conjunction with the above treatment plans or
if the above methods fail. These include physi-
cal stimulation of the penis to initiate spinal re-
ﬂexes, placing an elastic constricting band at the
base of the penis to prevent outﬂow of blood,
and vacuum devices designed to create negative
pressure facilitating cavernous blood ﬂow.72 There
are more invasive techniques, including the in-
tercavernosal injection of vasodilators, such as
papaverine or a combination of papaverine, phento-
lamine, and prostaglandin E1,75 or yohimbine.76,77
Additional methods of treatment include topical
nitroglycerine,78 topical minoxidil,79 and silde-
naﬁl, which has been shown to improve the quality
and frequency of erections, regardless of etiology
while not effecting libido.80 However, there are no
studies involving the drug sildenaﬁl in treatment of
patients suffering from epilepsy.
Conclusion
Sexual dysfunction in epileptic patients appears to
be multifactorial with no clearly deﬁned solitary
cause. Although many studies report the presence
of hormonal changes and sexual disorders in epilep-
tic patients, there are substantial differences in
both patient populations and characterization of
epilepsy and sexual disorders. Furthermore, a
clear majority of these studies report hormonal
changes attributable to epilepsy in patients who
are concurrently receiving anticonvulsant phar-
macologic therapy. Determining how prominent a
role antiepileptic medication plays in the develop-
ment of sexual dysfunction compared to hormonal
changes appears to be the least explored aspect
of this dilemma. However, it is almost impossible
to study epileptic patients na¨ıve to antiepileptic
medical therapy due to ethical considerations. In
order to more fully understand the etiology of
sexual dysfunction in epileptics, more attention
needs to be addressed in selecting patient popula-
tions. This can be attained by identifying patients
with epilepsy using standardized diagnostic cri-
teria, comparing reproductive hormonal levels of
hyposexual epileptic men with their asymptomatic
counterparts, comparing patients with similar and
different loci of epileptiform discharge and ﬁnally
characterizing speciﬁc reproductive endocrine dis-
orders in epileptic men more diligently.
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